Bolt Biotherapeutics Total Assets

Bolt Biotherapeutics (BOLT) currently reports a total assets of $40M as of June 2026. That compares with $75M in the prior-year period — down 46.6% year over year. Use the charts on this page to explore Bolt Biotherapeutics's total assets history and peer comparisons.

Bolt Biotherapeutics's total assets decreased from $75M to $40M — a 46.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bolt Biotherapeutics reported $40M in total assets as of June 2026. That compares with $75M in the prior-year period — down 46.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $40M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bolt Biotherapeutics, and consider following BOLT for alerts when major investors trade the stock.

Bolt Biotherapeutics is classified in the Healthcare sector. On total assets, it currently shows $40M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BOLT with unrelated industries.